Lymphomatoid papulosis

J Dtsch Dermatol Ges. 2020 Mar;18(3):199-205. doi: 10.1111/ddg.14041. Epub 2020 Feb 26.


Lymphomatoid papulosis (LyP) is characterized by a varied clinical presentation that includes erythema, papules, pustules, vesicles, plaques, nodules and ulcerations. While its biological course is typically marked by spontaneous regression, the histopathological findings of LyP are consistent with cutaneous T-cell lymphoma. Provided patients do no develop a secondary lymphoma, they exhibit unusually high 10-year survival rates (> 90 %), which is a typical feature of LyP. To date, the etiology and pathogenesis of LyP have not been elucidated. One particular subtype of LyP is known to be associated with chromosome 6p25.3 rearrangement (DUSP22-IRF4 translocation). Treatment is guided by the clinical presentation. In addition to a wait-and-see approach, recommended options include topical corticosteroids and PUVA therapy.

Publication types

  • Review

MeSH terms

  • Female
  • Humans
  • Lymphomatoid Papulosis / pathology*
  • Male
  • Skin Neoplasms / pathology*